MISOPROSTOL ALONE – Guidance for providers offering misoprostol-alone for abortion amidst Covid-19
CEDES and Gynuity Health Projects in collaboration with ASAP, CLACAI, REDAAS and Women Help Women are pleased to share a new resource for providers with access to misoprostol to ensure that safe medical abortion can still be offered during the Covid-19 pandemic and in accordance with social distancing practices. It was developed in response to an outspoken need among providers around the world. The guidance reviews the steps of providing misoprostol for medical abortion and makes evidence-based recommendations for limiting personal contact and reducing in-person visits.
The guidance is currently available on the websites of CEDES (en español) and Gynuity (in English) in a mobile-optimised format for viewing on a mobile phone or tablet. It will soon also be available in a printable format, as well as in French, Russian and Arabic.
SOURCE: CEDES/Gynuity statement, 10 July 2020